Check back frequently to get the latest news about Onduo. For inquiries, please contact us at

  1. Product1

    Onduo Virtual Care Solution Expands to Multi-Condition Platform with Spanish Language Support

    Onduo launched its new multi-condition platform that matches the right care to the right member at the right time. The expanded platform is designed to support members managing one or more chronic health conditions including type 2 diabetes, pre-diabetes, weight loss, hypertension, and mental wellness.

    Read full article
  2. Journal

    Onduo’s New Prospective Study Published in the Journal of Medical Internet Research

    Onduo released a whitepaper on the use of continuous glucose monitoring systems (CGMs) for type 2 diabetes care as part of a whole person health approach that supports people between visits with their primary care providers (PCPs).

    Read full article
  3. Library 2

    Onduo Data Presented at American Diabetes Association’s (ADA) 80th Scientific Sessions

    Onduo Data Presented at American Diabetes Association’s (ADA) 80th Scientific Sessions Highlights Meaningfully Lowered Hemoglobin A1C in People with T2D, with Significantly Greater Reductions in Participants Using Continuous Glucose Monitoring.

    Read full article
  4. Onduo Logo

    Onduo Appoints Verily’s Dr. Vindell Washington as Interim CEO to Lead Next Phase of Growth

    Onduo announced Dr. Vindell Washington will step in as interim CEO to lead the company during its next stage of growth. Vindell joined Verily as chief clinical officer of Health Platforms in January. Dr. Josh Riff, who has served as CEO since the launch of Onduo in 2016 is leaving to pursue other early-stage entrepreneurial opportunities.

    Read full article
  5. Library

    Onduo Presents Data on High Satisfaction and Positive Glycemic Outcomes

    Onduo shared positive research findings from the use of continuous glucose monitoring (CGM) systems by adults with type 2 diabetes participating in its virtual diabetes clinic. In a presentation at the 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), Onduo revealed results of a satisfaction survey completed by 594 members who wore a CGM.

    Read full article